Keel Point’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $215K | Sell |
3,000
-1,391
| -32% | -$107K | 0.01% | 433 |
|
|
2025
Q4 | $348K | Buy |
4,391
+263
| +6% | +$20.7K | 0.02% | 375 |
|
|
2025
Q3 | $311K | Buy |
4,128
+345
| +9% | +$23.6K | 0.02% | 402 |
|
|
2025
Q2 | $261K | Buy |
3,783
+187
| +5% | +$12.3K | 0.02% | 421 |
|
|
2025
Q1 | $244K | Buy |
+3,596
| New | +$215K | 0.02% | 399 |
|
|
2024
Q4 | – | Sell |
-4,548
| Closed | -$286K | – | 446 |
|
|
2024
Q3 | $286K | Sell |
4,548
-55,829
| -92% | -$3.26M | 0.02% | 334 |
|
|
2024
Q2 | $3.37M | Buy |
60,377
+3,750
| +7% | +$235K | 0.3% | 64 |
|
|
2024
Q1 | $4.52M | Buy |
56,627
+8,568
| +18% | +$654K | 0.47% | 45 |
|
|
2023
Q4 | $3.79M | Buy |
48,059
+6
| +0% | +$427 | 0.45% | 49 |
|
|
2023
Q3 | $3.36M | Sell |
48,053
-675
| -1% | -$47.8K | 0.46% | 47 |
|
|
2023
Q2 | $3.37M | Buy |
48,728
+1,229
| +3% | +$87.4K | 0.45% | 50 |
|
|
2023
Q1 | $3.53M | Buy |
47,499
+9,921
| +26% | +$832K | 0.51% | 47 |
|
|
2022
Q4 | $3.5M | Sell |
37,578
-157
| -0.4% | -$15.1K | 0.55% | 45 |
|
|
2022
Q3 | $3.6M | Sell |
37,735
-4,868
| -11% | -$482K | 0.62% | 33 |
|
|
2022
Q2 | $4.43M | Buy |
42,603
+594
| +1% | +$58K | 0.69% | 31 |
|
|
2022
Q1 | $4.25M | Sell |
42,009
-3,633
| -8% | -$382K | 0.64% | 37 |
|
|
2021
Q4 | $4.71M | Buy |
45,642
+1,517
| +3% | +$140K | 0.53% | 37 |
|
|
2021
Q3 | $3.74M | Buy |
44,125
+2,509
| +6% | +$210K | 0.48% | 42 |
|
|
2021
Q2 | $3.47M | Sell |
41,616
-1,140
| -3% | -$93.4K | 0.39% | 53 |
|
|
2021
Q1 | $3.22M | Buy |
42,756
+937
| +2% | +$68.3K | 0.31% | 49 |
|
|
2020
Q4 | $2.86M | Buy |
41,819
+5,596
| +15% | +$364K | 0.25% | 64 |
|
|
2020
Q3 | $2.12M | Buy |
36,223
+10,963
| +43% | +$682K | 0.19% | 74 |
|
|
2020
Q2 | $1.64M | Buy |
25,260
+1,427
| +6% | +$89.9K | 0.17% | 67 |
|
|
2020
Q1 | $1.41M | Buy |
23,833
+1,197
| +5% | +$79.9K | 0.18% | 52 |
|
|
2019
Q4 | $1.68M | Buy |
22,636
+1,606
| +8% | +$113K | 0.18% | 53 |
|
|
2019
Q3 | $1.33M | Buy |
21,030
+1,214
| +6% | +$71.9K | 0.16% | 61 |
|
|
2019
Q2 | $1.08M | Buy |
19,816
+2,662
| +16% | +$143K | 0.12% | 74 |
|
|
2019
Q1 | $925K | Buy |
17,154
+6,227
| +57% | +$384K | 0.11% | 78 |
|
|
2018
Q4 | $716K | Buy |
10,927
+6,392
| +141% | +$477K | 0.1% | 84 |
|
|
2018
Q3 | $357K | Buy |
4,535
+879
| +24% | +$62.8K | 0.04% | 127 |
|
|
2018
Q2 | $235K | Buy |
+3,656
| New | +$241K | 0.03% | 147 |
|
|
2017
Q3 | – | Sell |
-3,824
| Closed | -$308K | – | 161 |
|
|
2017
Q2 | $308K | Buy |
3,824
+528
| +16% | +$41.7K | 0.06% | 121 |
|
|
2017
Q1 | $259K | Buy |
3,296
+22
| +0.7% | +$1.76K | 0.05% | 137 |
|
|
2016
Q4 | $258K | Buy |
3,274
+963
| +42% | +$77.9K | 0.06% | 131 |
|
|
2016
Q3 | $206K | Buy |
+2,311
| New | +$218K | 0.08% | 124 |
|
Other funds holding CVS
VCM
VPM
Keel Point's CVS Position: Q1 2026 in Review
Keel Point reduced its CVS Health (CVS) stake by 32% in Q1 2026, selling an estimated $107K and leaving 3,000 shares worth $215K. The position accounts for 0.01% of the portfolio, ranked #433.
Keel Point first reported a position in CVS in Q3 2016 and has held it in 35 quarters since. The position peaked at $4.71M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Keel Point held 3,000 shares of CVS Health worth $215K as of Q1 2026.
- Keel Point sold 1,391 CVS Health shares in Q1 2026, an estimated $107K.
- CVS Health made up 0.01% of Keel Point's portfolio in Q1 2026, its #433 holding.
- Keel Point first reported a position in CVS Health in Q3 2016 and has held it in 35 quarters since.
- Keel Point's CVS Health position peaked at $4.71M in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.